During angiogenesis, vascular endothelial growth factor regulate natural killer cell adhesion to tumor endothelium
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Localization of activated natural killer (A-NK) cells in the microvasculature of growing tumors is the result of recognition of the intracellular and vascular cell-adhesion molecules ICAM-1 and VCAM-1 on the tumor endothelium, mediated by lymphocyte function-associated protein LFA-1 and vascular lymphocyte function-associated protein VLA-4. In vitro and in vivo studies of A-NK cell adhesion to endothelial cells showed that vascular endothelial growth factor (VEGF) promotes adhesion, whereas basic fibroblast growth factor (bFGF) inhibits adhesion through the regulation of these molecules on tumor vasculature. Thus, some angiogenic factors may facilitate lymphocyte recognition of angiogenic vessels, whereas others may provide such vessels with a mechanism that protects them from cytotoxic lymphocytes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Angiogenic molecules present in the TME, such as VEGF (FIG. 1), can control the trafficking of immune cells to the tumour by altering the expression of adhesion molecules, including the integrin ligands intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion protein 1 (VCAM1), on endothelial cells (ECs) and immune cells10,14,15”
From Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges (2018) · cites this paper as [14]
Citations
Cites
Dvorak, H. F., Brown, L. F., Detmar, M. J., & Dvořàk, A. M. (1995) · Europe PMC (PubMed Central) · Cited by 3,115
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262
Determinants of tumor blood flow: a review.
Jain, R. K. (1988) · PubMed · Cited by 1,379
Self-citationDefinition of Two Angiogenic Pathways by Distinct α v Integrins
Friedlander, M., Brooks, P. C., Shaffer, R. W., Kincaid, C. M., Varner, J. A., & Cheresh, D. A. (1995) · Science · doi:10.1126/science.270.5241.1500 · Cited by 1,321
Busch, H. (1969) · The American Journal of the Medical Sciences · doi:10.1097/00000441-196906000-00015 · Cited by 1,205
The implications of angiogenesis for the biology and therapy of cancer metastasis
Fidler, I. (1994) · Cell · doi:10.1016/0092-8674(94)90187-2 · Cited by 1,098
Leukocyte adhesion to endothelium in inflammation
Osborn, L. (1990) · Cell · doi:10.1016/0092-8674(90)90230-c · Cited by 865
Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1
Koch, A. E., Halloran, M. M., Haskell, C. J., Shah, M. R., & Polverini, P. J. (1995) · Nature · doi:10.1038/376517a0 · Cited by 600
Characterization of ICAM-2 and evidence for a third counter-receptor for LFA-1.
de Fougerolles, A. R., Stacker, S. A., Schwarting, R., & Springer, T. A. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.1.253 · Cited by 495
Yuan, F., Salehi, H. A., Boucher, Y., Vasthare, U. S., Tuma, R. F., & Jain, R. K. (1994) · PubMed · Cited by 463
Self-citation
Research works printed but not linked: 2
- Wu, N.Z., Klitzman, B., Dodge, R. & Dewhirst, M.W. iminished leukocyteendothelium interaction in tumor microvessels. Cancer Res. 52, 4265–4268 (1992).
- Dellian, M., Witwer, B.P., Salehi, H.A., Yuan, F. & Jain, R. uantitation and physiological characterization of angiogenic vessels in mice. Am. J. Pathol. 149, 59–71 (1996).
Cited by
Items 301–400 of 482
Novel Hyperactive Mitogen to Endothelial Cells: Human Decidual NKG5
Langer, N., Beach, D., & Lindenbaum, E. S. (1999) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1999.tb00100.x · Cited by 22
Aoki, M., Kanamori, M., Ohmori, K., Takaishi, M., Huh, N., Nogami, S., & Kimura, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.009 · Cited by 21
Wound Healing: Findings of the 2005 AAOMS Research Summit
Le, A. D., Basi, D. L., & Abubaker, A. O. (2005) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2005.07.007 · Cited by 21
Vascular and Interstitial Biology of Tumors
Jain, R. K., Chauhan, V. P., & Duda, D. G. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00008-4 · Cited by 21
Self-citationAssociation of endometriosis with Sjögren's syndrome: Genetic insights (Review)
Zervou, M. I., Tarlatzis, B. C., Grimbizis, G., Spandidos, D. A., Niewold, T. B., & Goulielmos, G. N. (2024) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2024.5344 · Cited by 20
Model of vascular desmoplastic multispecies tumor growth
Ng, C. F., & Frieboes, H. B. (2017) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2017.05.013 · Cited by 21
Iacono, O. L., Rincón, D., Hernando, A., Ripoll, C., Catalina, M., Salcedo, M., Clemente, G., Gomez, J., Martínez, Ó. N., Matilla, A. M., et al. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01763.x · Cited by 20
Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment
Batista, A., Riedemann, L., Vardam, T. D., & Jain, R. K. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000125 · Cited by 19
Self-citationYang, Y., Bai, Y., ., G. X., Zhang, N., Ma, Y., Chen, L., Jiang, Y., Zhao, X., Wei, Y.-Q., & Deng, H. (2010) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2009.0692 · Cited by 19
Jeffes, E. W. B., Zhang, J. G., Hoa, N. T., Petkar, A., Delgado, C., Chong, S., Obenaus, A., Sanchez, R., Khalaghizadeh, S., Khomenko, T., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2533 · Cited by 19
Increased Leukocyte Rolling in Newly Formed Mesenteric Vessels in the Rat during Peritoneal Dialysis
Zarei, M., van Lambalgen, A. A., Vriese, A. S. D., Gelderop, E. V., Lameire, N. H., ter Wee, P. M., Beelen, R. H. J., van den Born, J., & Tangelder, G. J. (2002) · Peritoneal Dialysis International · doi:10.1177/089686080202200603 · Cited by 19
Zhou, Z., Zhong, H., Wang, H., Wang, S., Kridis, W. B., Wang, R., Shen, K., Wang, Z., & Huang, R. (2025) · Discover Oncology · doi:10.1007/s12672-025-03797-1 · Cited by 18
Role of Inflammation in Diabetic Retinopathy
Sharma, A., & Arora, D. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100175 · Cited by 18
Angiostasis as a way to improve immunotherapy
Vyth‐Dreese, F. A., & Griffioen, A. W. (2009) · Thrombosis and Haemostasis · doi:10.1160/th08-08-0552 · Cited by 18
Mariotti, M., & Maier, J. A. M. (2006) · Springer eBooks · doi:10.1007/1-4020-4327-9_1 · Cited by 18
Advanced in vitro models for renal cell carcinoma therapy design
Mieville, V., Griffioen, A. W., Benamran, D. A., & Nowak-Sliwinska, P. M. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188942 · Cited by 17
Saudi Arabia Guidelines for diabetic macular edema: A consensus of the Saudi Retina Group
AlQahtani, A. S., Hazzazi, M. A., Waheeb, S. A., Semidey, V. A., Semidey, V. A., Elgendy, H. M. K., Al-Khars, W., Abouammoh, M. A., & Al-Dhibi, H. A. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.2.25623 · Cited by 17
Tsunoda, S., Ohizumi, I., Matsui, J., Koizumi, K., Wakai, Y., Makimoto, H., Tsutsumi, Y. M., Utoguchi, N., Taniguchi, K., Saito, H., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690823 · Cited by 17
Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
Evans, S. S., Fisher, D. T., Skitzki, J. J., & Chen, Q. (2008) · International Journal of Hyperthermia · doi:10.1080/02656730701772498 · Cited by 17
Natural killer cells, adhesion and tumor angiogenesis
Ferrara, N. (1996) · Nature Medicine · doi:10.1038/nm0996-971 · Cited by 17
Jain, R. K., Martin, J. D., Chauhan, V. P., & Duda, D. G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00008-6 · Cited by 16
Self-citationTotality of evidence in the development of ABP 215, an approved bevacizumab biosimilar
Thomas, M., Thatcher, N., Goldschmidt, J. H., Ohe, Y., McBride, H. J., & Hanes, V. (2019) · Immunotherapy · doi:10.2217/imt-2019-0125 · Cited by 16
Lymphangiogenesis in Cancer: Current Perspectives
Liersch, R., Biermann, C., Mesters, R. M., & Berdel, W. E. (2009) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-540-78281-0_8 · Cited by 16
Protective Effects of Basic Fibroblast Growth Factor in Early Atherosclerosis
Six, I., Mouquet, F., Corseaux, D., Bordet, R., Tourneau, T. L., Vallet, B., Dosquet, C., Dupuis, B., Jude, B., Bertrand, M. E., et al. (2004) · Growth Factors · doi:10.1080/08977190410001724505 · Cited by 16
Regulation of Leukocyte-Endothelial Cell Interactions in Tumor Immunity
Evans, S. S., Frey, M., Schleider, D. M., Bruce, R. A., Wang, W., Repasky, E. A., & Appenheimer, M. M. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1352-4_21 · Cited by 16
Jain, R. K., Munn, L. L., & Fukumura, D. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-100-8_34 · Cited by 15
Self-citationTargeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma
Podar, K., Richardson, P. G. G., Chauhan, D., & Anderson, K. C. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.551 · Cited by 15
Sho, M., Akashi, S., Kanehiro, H., Hamada, K., Kashizuka, H., Ikeda, N., Nomi, T., Kuzumoto, Y., Tsurui, Y., Yoshiji, H., et al. (2005) · Transplantation · doi:10.1097/01.tp.0000173650.83320.b1 · Cited by 15
Tobelem, G. (2007) · Targeted Oncology · doi:10.1007/s11523-007-0051-8 · Cited by 15
Sarker, K. P., Yamahata, H., Nakata, M., Arisato, T., Nakajima, T., Kitajima, I., & Maruyama, I. (1999) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022522 · Cited by 15
Li, Y., Yang, L., & Zd, L. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104883 · Cited by 14
Experimental models of growth factor-mediated angiogenesis and blood–retinal barrier breakdown
Vinores, S. A., Seo, M. S., Okamoto, N., Ash, J. D., Wawrousek, E. F., Xiao, W.-H., Hudish, T. M., Derevjanik, N. L., & Campochiaro, P. A. (2000) · General Pharmacology The Vascular System · doi:10.1016/s0306-3623(01)00117-3 · Cited by 14
Cellular mechanisms of blood-retinal barrier dysfunction in macular edema
Vinores, S. A., Derevjanik, N. L., Ozaki, H., Okamoto, N., & Campochiaro, P. A. (2000) · Springer eBooks · doi:10.1007/978-94-011-4152-9_2 · Cited by 14
The angiogenic factor bFGF impairs leukocyte adhesion and rolling under flow conditions
Griffioen, A. W., Relou, I. A. M., Torres, H. I. G., Damen, C. A., Martinotti, S., de Graaf, J. C., Zwaginga, J. J., & Groenewegen, G. (1998) · Angiogenesis · doi:10.1023/a:1009237324501 · Cited by 14
“This is in line with earlier ®ndings that (i) bFGF suppresses transendothelial emigration of CD4T lymphocytes(14) and (ii) that bFGF reduces natural killer cell adhesion to tumor interstitial ̄uid treated HUVEC.(25) It should be noted, however, that in some tumors such as breast carcinoma and hemangioma an elevated E-…”
ResultChen, S., Wei, H., Zhao, W., Jiang, W., Ning, R., Zhou, S., Tan, L., Wang, H., Su, C., He, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1059995 · Cited by 13
Lin, I.-C., Sheen, J., Tain, Y., Chou, M.-H., Huang, L., & Yang, K. D. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0612 · Cited by 13
Angiogenesis and organ transplantation
Rajnoch, J., & Viklický, O. (2004) · Folia Microbiologica · doi:10.1007/bf02931524 · Cited by 13
“Abbreviations Ang-1 angiopoietin 1 ICAM-1 intercellular adhesion molecule-1 Ang-2 angiopoietin 2 IL-2 interleukin 2 APC antigen-presenting cell I–”
BackgroundLiliensiek, B., Rocha, M., Umansky, V., Benner, A., Lin, J., Ziegler, R., Nawroth, P. P., & Schirrmacher, V. (1998) · Blood · doi:10.1182/blood.v92.9.3394 · Cited by 13
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma
Mair, M. J., Ilhan‐Mutlu, A., Pajenda, S., Kiesel, B., Wöehrer, A., Widhalm, G., Dieckmann, K. U., Marosi, C., Wagner, L., Preusser, M., et al. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02951-2 · Cited by 12
Jain, R. K., Munn, L. L., & Fukumura, D. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-968-0_26 · Cited by 12
Self-citationBex, A., Etto, T. L., Vyth‐Dreese, F. A., Blank, C. U., & Griffioen, A. W. (2012) · Current Oncology Reports · doi:10.1007/s11912-012-0229-9 · Cited by 12
Gapizov, S. S., Petrovskaya, L. E., Shingarova, L. N., Svirschevskaya, E. V., Dolgikh, D. A., & Kirpichnikov, M. P. (2018) · Acta Naturae · doi:10.32607/20758251-2018-10-1-34-42 · Cited by 12
Qian, Y., Ding, L., Cao, L., Yu, Z., Shao, X., Wang, X., Zhang, M., Wang, Q., Che, X., Jiang, N., et al. (2022) · BMC Nephrology · doi:10.1186/s12882-022-02975-5 · Cited by 12
Taghizadeh, S., Sankian, M., Ajami, A., Tehrani, M., Hafezi, N., Mohammadian-Amiri, R., Farazmandfar, T., Hosseini, V., Abbasi, A., & Ajami, M. (2014) · Journal of the Korean Gastric Cancer Association · doi:10.5230/jgc.2014.14.3.196 · Cited by 12
The strange Microenvironment of Glioblastoma
Brisson, L., Geraldo, L. H., Bikfalvi, A., & Mathivet, T. (2023) · Revue Neurologique · doi:10.1016/j.neurol.2023.03.007 · Cited by 11
Panahi, Y., Milani, A. E., Sahebkar, A., Naderi, M., Babaei, M., Beiraghdar, F., Parvin, S., & Dadjou, Y. (2011) · Cutaneous and Ocular Toxicology · doi:10.3109/15569527.2011.615359 · Cited by 11
Zinser-Sierra, J. W., Rodríguez‐Ramírez, S. E., Villalobos-Valencia, R., & Ramírez-Márquez, M. (2011) · Drugs in R&D · doi:10.1007/bf03259800 · Cited by 11
Kawata, N., Yagasaki, H., Yuge, H., Nakanoya, Y., Fujimura, K., Sugimoto, S., Hirakata, H., & Takimoto, Y. (2001) · International Journal of Urology · doi:10.1046/j.1442-2042.2001.00299.x · Cited by 11
Cellular Therapy of Cancer with Natural Killer Cells: Will It Ever Work?
Klingemann, H.-G. (2001) · Stem Cells and Development · doi:10.1089/152581601750098174 · Cited by 11
Pathogenetic Mechanisms in Diabetic Retinopathy: From Molecules to Cells to Tissues
Biswas, S., & Chakrabarti, S. (2017) · Springer eBooks · doi:10.1007/978-3-319-60324-7_9 · Cited by 10
PLXDC1 Can Be a Biomarker for Poor Prognosis and Immune Evasion in Gastric Cancer
Li, X., Fan, Y., Tang, M., Li, H., Zhang, Y., Mi, J., Wang, Y., Zhao, M., Wang, Z., & Su, F. (2022) · Journal of Inflammation Research · doi:10.2147/jir.s383191 · Cited by 10
Wang, Y., Wang, B., Xiang, L., Deng, J., Xu, B., He, P., Pu, W., Wang, H., Fan, Y., & Chen, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1016647 · Cited by 10
“As a result of multiple immune-suppressive components being activated in the tumor microenvironment, immunotherapy in solid tumors is limited (44).”
BackgroundStassi, A. F., Díaz, P. U., Gasser, F. B., Velázquez, M. M. L., Gareis, N. C., Salvetti, N. R., Ortega, H. H., & Baravalle, M. E. (2022) · Theriogenology · doi:10.1016/j.theriogenology.2022.04.002 · Cited by 10
Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
Rossi, L., Zoratto, F., Zullo, A., Papa, A., Zaccarelli, E., Giordani, E., Baiano, G., Colonna, M., Tomao, L., & Tomao, S. (2012) · OncoTargets and Therapy · doi:10.2147/ott.s30581 · Cited by 10
Mohamed, M. K., Atef, A. A., Moemen, L. A., Azeem, A. A. A., Mohalhal, I. A., & Taha, A. M. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00401-9 · Cited by 9
Functional Similarity Assessment Results Comparing Bevacizumab to Biosimilar Candidate Abp 215
Born, T. L., Huynh, Q., Mathur, A., Velayudhan, J., Canon, J., Reynhardt, K. O., Goletz, T. J., & Markus, R. A. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu331.49 · Cited by 9
Intra-tumoral angiogenesis correlates with immune features and prognosis in glioma
Zhang, Q. H., Guo, Y., Zhang, W., Lian, H.-Y., Iranzad, N., Wang, E., Li, Y., Tong, H.-C., Li, L.-Y., Dong, L.-Y., et al. (2022) · Aging · doi:10.18632/aging.204079 · Cited by 9
Kawasaki Disease: Four Case Reports of Cardiopathy with an Institutional and Literature Review
Ashrafi, A. H., Wang, J., Stockwell, C. A., Lloyd, D., McAlvin, J. B., Russo, P., & Shehata, B. M. (2007) · Pediatric and Developmental Pathology · doi:10.2350/06-10-0172.1 · Cited by 9
Tumour Angiogenesis and Metastasis: The Regulatory Role of Hyaluronan and Its Degradation Products
West, D. C., Shaw, D. M., & Joyce, M. (1998) · Springer eBooks · doi:10.1007/978-1-4757-9185-3_32 · Cited by 9
Angiogenesis and Allograft Rejection
Reinders, M. E. J., & Briscoe, D. M. (2002) · Graft · doi:10.1177/1522162802005002008 · Cited by 9
Ryan, A. W. (2002) · Frontiers in bioscience · doi:10.2741/wilcox · Cited by 9
Wittig, B. M., Treichel, U., Blaheta, R. A., Schreiter, T., Schwarting, A., Büschenfelde, K. M. Z., & Mayet, W. J. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3786 · Cited by 9
Small GTPase and Regulation of Inflammation Response in Atherogenesis
Lu, Y., Peng, W., & Xu, Y. (2013) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3182a12eb3 · Cited by 8
Candidate Gene Analysis of Mortality in Dialysis Patients
Rothuizen, T. C., Ocak, G., Verschuren, J. J. W., Dekker, F. W., Rabelink, T. J., Jukema, J. W., & Rotmans, J. I. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143079 · Cited by 8
Continuous Infusion Interleukin-2 and Intravenous Famotidine in Metastatic Melanoma
Quan, W., Milligan, K., Quan, F. M., Cuenca, R. E., Khan, N., Liles, D., & Walker, P. R. (2006) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2006.21.607 · Cited by 8
Hyaluronan Oligosaccharides Promote Wound Repair
West, D. C., & Fan, T. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-126-8_11 · Cited by 8
Monsalve, C., & Estela, D. (2011) · e_Buah · Cited by 8
Sarin, H. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0707-6 · Cited by 8
Hall, B., Żebrowska, A., Sikora, M., Siatkowski, S., & Robins, A. (2023) · Nutrients · doi:10.3390/nu15173749 · Cited by 7
“VEGF is an established stimulator of physiological and pathophysiological angiogenesis [11,12], whilst it also acts as a pro-inflammatory cytokine by increasing the permeability of the endothelial barrier and by being chemotactic for monocytes [13,14].”
BackgroundResearch Progress of Nanomaterials Acting on NK Cells in Tumor Immunotherapy and Imaging
Feng, Y., Zhang, H., Shao, J., Du, C., Zhou, X., Guo, X., & Wang, Y. (2024) · Biology · doi:10.3390/biology13030153 · Cited by 7
Effect of rhPDGF-BB Delivery on Mediators of Periodontal Wound Repair
Cooke, J. W., Sarment, D. P., Whitesman, L. A., Miller, S. E., Jin, Q., Lynch, S. E., & Giannobile, W. V. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.ft-93 · Cited by 7
Vascular and Interstitial Biology of Tumors
Jain, R. K., & Duda, D. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50011-7 · Cited by 7
Self-citationLópez-Ocejo, O., Perea, S. E., Béquet‐Romero, M., Araña, M. J., & Saura, P. L. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3690 · Cited by 7
Vascular endothelial growth factor-A mRNA gene expression in clinical phases of multiple sclerosis
Rasol, H. A. A., Helmy, H., Mously, S. E., Aziz, M. A., & bahaie, H. E. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215584957 · Cited by 6
Aflibercept treatment in patients with diabetic macular edema
Astakhov, Y. S., & Nechiporenko, P. A. (2017) · Ophthalmology Reports · doi:10.17816/ov10294-109 · Cited by 6
Kang, S. K., Kang, K., Jee, M. K., & Kim, B. S. (2010) · Tissue Engineering Part A · doi:10.1089/ten.tea.2010.0010 · Cited by 6
RetractedPathophysiology of ischaemia-reperfusion injury
Carden, D. L., & Granger, D. N. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200002)190:3 · Cited by 5
Normalizing the Tumor Microenvironment for Radiosensitization
Martin, J. D., & Jain, R. K. (2020) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-030-49701-9_12 · Cited by 5
Self-citationKoop, E. A., & Voest, E. E. (2002) · Elsevier eBooks · doi:10.1016/b978-012072651-6/50008-5 · Cited by 5
Clinical significance of angiogenic factors in breast cancer
Locopo, N., Fanelli, M., & Gasparini, G. (1998) · Springer eBooks · doi:10.1007/978-1-4615-5195-9_20 · Cited by 5
Intratumoral Fibrosis: Emerging Concepts and Therapeutic Opportunities
Cremasco, V., & Chang, J. J. (2020) · Royal Society of Chemistry eBooks · doi:10.1039/9781788015783-00259 · Cited by 4
Unveiling VCAM‐1’s Multifaceted Role in Secondary Diabetic Complications
Kaur, P., Ritu, Sharma, K., Goyal, R. K., Basist, P., Khan, R., & Alhalmi, A. (2025) · Journal of Food Quality · doi:10.1155/jfq/9206712 · Cited by 4
Duignan, S. M., Brennan, K., Connolly, E., Watson, A., Noone, D., Dunne, E., Gavin, P. J., Flinn, A. M., Maoldomhnaigh, C. Ó., Doyle, S., et al. (2025) · Pediatric Cardiology · doi:10.1007/s00246-025-03989-0 · Cited by 4
Yulinda, D., Yueniwati, Y., & Nurseta, T. (2014) · Journal of Experimental and Integrative Medicine · doi:10.5455/jeim.140414.br.022 · Cited by 4
“It is capable of acting as a pro-inflammatory cytokine by increasing the permeability of endothelial cells and inducing the expression of endothelial adhesion molecules, thus acting as a chemoattractant of monocytes and macrophages [10-13].”
BackgroundXu, J., Tian, Y., Hu, D., Xi, Y., & Yang, L. (2024) · MedComm – Oncology · doi:10.1002/mog2.85 · Cited by 5
Gu, S., Furukawa, H., & Yamashita, A. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620050019 · Cited by 4
St‐Pierre, Y. (2005) · Frontiers in bioscience · doi:10.2741/1597 · Cited by 4
The role of VEGF and other parameters in tracking the clinical course in metronomic chemotherapy.
Ekinci, D., Ekici, D., Kargı, A., Yalçın, A. D., Yalçın, A. D., & Savaş, B. (2013) · PubMed · Cited by 3
Tumor Vascular Remodeling Affects Molecular Dissemination to Lymph Node and Systemic Leukocytes
O’Melia, M. J., Rohner, N. A., & Thomas, S. N. (2022) · Tissue Engineering Part A · doi:10.1089/ten.tea.2022.0020 · Cited by 3
Aqueous Humor Factors' Predictive Effects in Treating Refractor Macular Edema: An Overview
Zhang, J., Yan, H., Li, J., & Li, B. (2022) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2022.0082 · Cited by 3
“In pathological conditions, its roles also include upregulating the expression of VCAM-1 and ICAM-1, promoting the adhesion of natural killer cells to the surface of endothelial cells, and thus participating in angiogenesis (Melder et al, 1996).”
Sterzyńska, K., Sujka‐Kordowska, P., & Witkiewicz, W. (2011) · Postepy Biologii Komorki · doi:10.2478/v10052-011-0004-3 · Cited by 3
Quan, W., Khan, N., Ramirez, M., Taylor, W. C., Quan, F. M., Vinogradov, M., & Walker, P. R. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.151 · Cited by 3
Rho, S. H., Yoon, H. S., Yoo, K. W., Park, W. C., Jeong, J. H., & Yoo, Y. H. (2000) · Ophthalmic Research · doi:10.1159/000055637 · Cited by 3
Podsiadło, K., Sułkowski, G., Dąbrowska‐Bouta, B., & Strużyńska, L. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0312-9 · Cited by 3
Angiogenesis in Development, Disease, and Regeneration
Jain, R. K., & Fukumura, D. (2008) · Springer eBooks · doi:10.1007/978-0-387-74660-9_6 · Cited by 3
Self-citationKikuchi, H. (2000) · Japanese Journal of Clinical Immunology · doi:10.2177/jsci.23.12 · Cited by 3
Thakur, C. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-812218-1.00002-6 · Cited by 3
McGrath, J. A., & BREATHNACH, S. M. (2004) · Wiley eBooks · doi:10.1002/9780470750520.ch11 · Cited by 3
Cutaneous Response to Injury and Wound Healing
O’Toole, E. A. (2016) · Wiley eBooks · doi:10.1002/9781118441213.rtd0010 · Cited by 3
Circulating Levels of VEGF , mTOR and MAPK in Patients With Port‐Wine Stains
Huang, Y., Wu, P., Yang, J. M., Bi, M., Cao, L., & Wang, L. (2025) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70232 · Cited by 2
Metadata
- Authors
- Melder, R. J., Koenig, G. C., Witwer, B. P., Safabakhsh, N., Munn, L. L., & Jain, R. K.
- Affiliations
- Massachusetts General Hospital (US)
- Harvard University (US)
- Venue
- Nature Medicine
- Published
- 1996-09
- Volume
- 2
- Issue
- 9
- Pages
- 992-997
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W304295984
- Cited by
- 451
- References
- 39
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 7 · 2023: 11 · 2022: 16 · 2021: 13 · 2020: 8 · 2019: 4 · 2018: 7 · 2017: 11 · 2016: 7 · 2015: 8 · 2014: 16 · 2013: 10 · 2012: 9
- FWCI
- 9.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1f32ca061631-01a2)
- National Cancer Institute (F32-CA 61631, R35CA056591, R35-CA-56591)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- natural killer cells, tumor endothelium, angiogenesis, vascular endothelial growth factor, basic fibroblast growth factor, cell adhesion, ICAM-1, VCAM-1, LFA-1, VLA-4, tumor vasculature, cytotoxic lymphocytes
- MeSH terms
- Animals, Cell Adhesion, Endothelium, Vascular, Humans, Lymphokines, Neoplasms, Experimental, Neovascularization, Pathologic, Tumor Cells, Cultured, Killer Cells, Lymphokine-Activated, Lymphocyte Function-Associated Antigen-1, Fibroblast Growth Factor 2, Endothelial Growth Factors, Mice, SCID, Intercellular Adhesion Molecule-1, P-Selectin, Vascular Cell Adhesion Molecule-1, E-Selectin, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.